NeilEMartinMDMPH

PubMed

• 33 citations
  Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.
  Nikhil G. Thaker, Thomas J. Pugh, Usama Mahmood, Seungtaek Choi, Tracy E. Spinks
  Brachytherapy. 2015-05-01
• 69 citations
  Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States
  Ayal A. Aizer, Xiangmei Gu, Ming-Hui Chen, Toni K. Choueiri, Neil E. Martin
  Journal of the National Comprehensive Cancer Network. 2015-01-01
• 16 citations
  Beta-Carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians' Health Study
  Danielle N. Margalit, Julie L. Kasperzyk, Neil E. Martin, Howard D. Sesso, John Michael Gaziano
  International Journal of Radiation Oncology, Biology, Physics. 2012-05-01

Journal Articles

• The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act  
  Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Lago-Hernandez C, Chen YW, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Trinh QD, Nguyen PL, Prostate Cancer Prostatic Dis, 9/1/2014
• Association of Androgen Deprivation Therapy with Excess Cardiac-Specific Mortality in Men with Prostate Cancer  
  Ziehr DR, Chen MH, Zhang D, Braccioforte MH, Moran BJ, Mahal BA, Hyatt AS, Basaria SS, Beard CJ, Beckman JA, Choueiri TK, D'Amico AV, Hoffman KE, Hu JC, Martin NE, Swe..., BJU Int, 8/15/2014
• Vasectomy and Risk of Aggressive Prostate Cancer: A 24-Year Follow-Up Study  
  Siddiqui MM, Wilson KM, Epstein MM, Rider JR, Martin NE, Stampfer MJ, Giovannucci EL, Mucci LA, J Clin Oncol, 7/7/2014
• Role of Androgen Deprivation Therapy in Early Salvage Radiation Among Patients With Prostate-Specific Antigen Level of 05 or Less  
  Parekh A, Chen MH, Graham P, Mahal BA, Hirsch AE, Nakabayashi M, Evan C, Kantoff PW, Martin NE, Nguyen PL, Clin Genitourin Cancer, 6/27/2014
• Weight gain on androgen deprivation therapy: which patients are at highest risk?  
  Seible DM, Gu X, Hyatt AS, Beard CJ, Choueiri TK, Efstathiou JA, Miyamoto DT, Mitin T, Martin NE, Sweeney CJ, Trinh QD, Beckman JA, Basaria S, Nguyen PL, Urology, 6/1/2014
• Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results  
  Mahal BA, Ziehr DR, Hyatt AS, Neubauer-Sugar EH, O'Farrell DA, O'Leary MP, Steele GS, Niedermayr TR, Beard CJ, Martin NE, Orio PF, D'Amico AV, Devlin PM, Nguyen P, Brachytherapy, 5/28/2014
• Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer  
  Urol Oncol, 5/17/2014
• Racial Disparities in Prostate Cancer-Specific Mortality in Men With Low-Risk Prostate Cancer  
  Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Hoffman KE, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Trinh QD, Nguyen PL, Clin Genitourin Cancer, 5/9/2014
• Refusal of Curative Radiation Therapy and Surgery Among Patients With Cancer  
  Aizer AA, Chen MH, Parekh A, Choueiri TK, Hoffman KE, Kim SP, Martin NE, Hu JC, Trinh QD, Nguyen PL, Int J Radiat Oncol Biol Phys, 5/3/2014
• Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG  
  Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kanto..., J Natl Cancer Inst, 12/18/2013
• Protein Expression of PTEN, Insulin-Like Growth Factor I Receptor (IGF-IR), and Lethal Prostate Cancer: A Prospective Study  
  Zu K, Martin NE, Fiorentino M, Flavin R, Lis RT, Sinnott JA, Finn S, Penney KL, Ma J, Fazli L, Gleave ME, Bismar TA, Stampfer MJ, Pollak MN, Loda M, Mucci LA, Giovannu..., Cancer Epidemiol Biomarkers Prev, 11/1/2013
• Marital status and survival in patients with cancer  
  Aizer AA, Chen MH, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, Graham PL, Choueiri TK, Hoffman KE, Martin NE, Hu JC, Nguyen PL, J Clin Oncol, 11/1/2013
• Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer  
  Parekh A, Chen MH, D'Amico AV, Dosoretz DE, Ross R, Salenius S, Graham PL, Beckman JA, Beard CJ, Choueiri TK, Ennis RD, Hoffman KE, Hu JC, Ma J, Martin NE, Nguyen PL, Brachytherapy, 9/1/2013
• Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: Implications for the use of newer isotopes  
  Kovtun KA, Wolfsberger L, Niedermayr T, Sugar EN, Graham PL, Murciano-Goroff Y, Beard C, D'Amico AV, Martin NE, Orio PF, Nguyen PL, Brachytherapy, 8/1/2013
• A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome After Radiation Therapy for Localized Prostate Cancer  
  Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA, Clin Canc Res, 3/15/2013
• The TMPRSS2:ERG rarrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis  
  Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon A, Suppan C, Flavin R, Sesso H, Rider JR, Sweeney CS, Stampfer MJ, Fio..., Cancer Epidemiology, Biomarkers & Prevention, 9/1/2012
• Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade  
  Martin NE, Chen M, Nguyen PL, Beard CJ, Loffredo MJ, Kantoff PW, D'Amico AV, BJU Int., 5/4/2012
• Influence of Androgen Deprivation Therapy on All-cause Mortality in Men with High-risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction  
  Nguyen PL, Chen MH, Beckman JA, Beard CJ, Martin NE, Choueiri TK, Hu JC, Hoffman KE, Dosoretz DE, Moran BJ, Salenius SA, Braccioforte MH, Kantoff PW, D'Amico AV, Ennis RD, Int J Rad Oncol Biol Phys, 6/25/2011
• mRNA expression signature of Gleason grade predicts lethal prostate cancer  
  Penney K, Sinnott J, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark J, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman M, Sesso H, Setlur SR, Andersson S, Ma..., J Clin Oncol, 6/10/2011
• Immunohistochemical expression of BRCA1 and lethal prostate cancer  
  Fiorentino M, Judson G, Penney K, Flavin R, Stark J, Fiore C, Fall K, Martin NE, Ma J, Sinnott J, Giovannucci E, Stampfer M, Sesso H, Kantoff PK, Finn S, Loda M, Mucci L, Cancer Research, 1/1/2010
• Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas  
  Martin NE, Ng AK, Leuk Lymphoma, 9/10/2009
• The potential role of intensity modulated radiation therapy in the management of localized rectal cancer  
  Martin NE, Nawaz O, Kachnic LA, Current Colorectal Cancer Reports, 1/1/2008
• Case study: the role of postmastectomy radiation in node-negative breast tumors larger than 5 cm  
  Martin NE, Floyd S, Abi Raad R, Taghian A, American Journal of Hematology/Oncology, 5/1/2007
• Management of aortic disease in Marfan syndrome: a decision analysis  
  Kim SY, Martin NE, Hsia EC, Pyeritz RE, Albert DA, Archives of Internal Medicine, 1/1/2005
• Interstitial photodynamic therapy for prostate cancer: a developing modality  
  Martin NE, Hahn SM, Photodiagnosis and Photodynamic Therapy, 1/1/2004
• Join now to see all

Books/Book Chapters

• Comprehensive Textbook of Genitourinary Oncology 
  Chapter: Prostate Cancer: molecular pathology and biologic determinant. 
  Martin NE, Loda MEditors: Scardino P..Lippincott Williams & WilkinsEdition 4th,2011
• Advances in Radiation Oncology in Lung Cancer 
  Chapter: Molecular Biology and Genetics of Lung Cancer. 
  Martin NE, Hahn SM, McKenna WGEditors: Jeremic B..Springer, Berlin; Heidelberg; New York2005

Abstracts/Posters

• Adjuvant versus salvage radiation for prostate cancer.
  Neil E. Martin, MD, Brigham and Women's Hospital Blue Print Series, Boston, MA, 1/1/2013
• Tumor adiponectin signaling underlies the association between obesity and lethal outcome in prostate cancer.
  Martin NE, Gerke T, Loda M, Stampfer M, Finn S, Rider J, Mucci LA, Annual Meeting of the American Association for Cancer Research, 1/1/2012
• Integrated Signature of PI3K Pathway Activation in Prostate Cancer.
  Neil E. Martin, MD, NCI Translational Science Meeting, Washington, DC, 1/1/2011
• Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade.
  Martin NE, Chen MH, Nguyen PL, Beard C, Kantoff PW, D'Amico AV, American Society of Clinical Oncology Genitourinary Symposium, 1/1/2011
• "Signature of PI3K activation in prostate cancer."
  Neil E. Martin, MD, Prostate Cancer Foundation Scientific Retreat, New Investigator Forum, Incline Village, NV, 1/1/2009
• Creation and testing of an immunohistochemical and gene expression profile score for activation of the PI3K pathway in prostate adenocarcinoma.
  Martin NE, Sinnott JA, Fiorentino M, Fiore C, Fedele G, Nguyen PL, Finn S, Stampfer M, Andren O, Soderkvist P, Sandblom D, Johansson JE, Andersson SO, Fall K, Mucci LA..., Annual Meeting of the American Association for Cancer Research, 1/1/2009
• Dosimetric comparison of radiation techniques to the prone pelvis for rectal cancer: 3-field based on bony landmarks (2D) vs. 3-dimensional conformal (3D) vs. intensit...
  Martin NE, Nawaz AO, Shuller B, Kozak KR, Hong TS, Kachnic LA, Annual Meeting of the American Society for Therapeutic Radiology and Oncology, 1/1/2008
• Dose-limiting pneumonitis in a phase I trial of R115777 and radiation therapy (RT) for patients (Pts) with non-small cell lung cancer (NSCLC).
  Thukral AD, Mick R, Bernhard EJ, Stevenson JP, Friedberg JS, Martin NE, Smith D, Prendergast S, McKenna W, Hahn SM, Annual Meeting of the American Society for Therapeutic Radiology and Oncology, 1/1/2008
• Activation of the PI3K pathway in prostate cancer: association between gene expression profiling and immunohistochemical markers.
  Martin NE, Sinnott JA, Fiorentino M, Fiore C, Fedele G, Finn S, Nguyen PL, Mucci LA, Stampfer M, Loda M, American Association for Cancer Research: Targeting the PI3-Kinase Pathway in Cancer, 1/1/2008
• Join now to see all

Lectures

• "Improving Care in Prostate Cancer-From pathway to pathway." 
  University of Pennsylvania, Department of Radiation Oncology - 1/1/2014
• "1st Annual Uro-Oncology Conference" 
  Albert Einstein Hospital, Sao Paulo, Brazil - 1/1/2014
• "International Consortium on Health Outcome Measurement" 
  1/1/2013
• "Prostate cancer outcome set." 
  1/1/2013
• "Innovations in External Beam Radiation." 
  1/1/2012
• "Development of a molecular signature of PI3K activation in prostate cancer." 
  Cambridge, MA - 1/1/2010
• "A molecular signature of PI3K activation in prostate cancer." 
  Boston, MA - 1/1/2010
• "A signature of PI3K activation in prostate cancer." 
  Boston, MA - 1/1/2010
• "Signature of PI3K activation." 
  Danvers, MA - 1/1/2010
• "PI3K activation in prostate cancer." 
  Boston, MA - 1/1/2009
• Join now to see all

Other

• Webcast: "Postoperative radiation" 
  Neil E. Martin, MD, Prostate Health Education Network
  1/1/2013